ArticleSurgical case reports2026
Surgically Diagnosed Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia in Asymptomatic Patients.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionDiffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare pulmonary precursor lesion that is characterized by the diffuse proliferation of neuroendocrine cells within the airway epithelium. Because obtaining a surgical specimen for histological confirmation is often difficult, management strategies for asymptomatic patients are controversial. It is generally considered an indolent condition that is often managed conservatively. However, diagnosis can be difficult in asymptomatic patients because radiological findings may resemble those of early-stage lung cancer. CASE PRESENTATION: We present 2 cases of asymptomatic patients with DIPNECH who were detected incidentally during radiological surveillance. High-resolution CT revealed multiple pulmonary nodules in both patients, accompanied by subtle findings indicative of small-airway involvement, such as mosaic attenuation and air trapping. Despite normal laboratory findings, normal pulmonary function tests, and the absence of respiratory symptoms, serial imaging revealed slow but definite enlargement of a dominant pulmonary nodule, making it difficult to exclude malignancy with confidence. The 1st patient was a 63-year-old nonsmoking woman who was observed for multiple pulmonary nodules over 6 years. During this period, a centrally located dominant nodule in the left lower lobe gradually enlarged, prompting a diagnostic left lower lobectomy. In the 2nd case, a 51-year-old nonsmoking woman demonstrated progressive enlargement of a dominant nodule over 2 years, prompting video-assisted thoracoscopic segmentectomy. Histopathological examination in both patients confirmed DIPNECH, allowing for the exclusion of invasive malignancy and a comprehensive pathological assessment of neuroendocrine cell proliferation.
conclusionsThese cases illustrate a practical diagnostic challenge in patients with suspected DIPNECH who are asymptomatic. Although radiological surveillance is usually appropriate for indolent disease, the progressive enlargement of a dominant pulmonary nodule can limit the reliability of observation alone. Therefore, surgical resection can be justified as a diagnostic strategy within a multidisciplinary framework when malignancy cannot be confidently excluded, although careful patient selection and long-term surveillance remain essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.